From: targetedonc.com According to results from the multicenter PRO B trial (German Clinical Trials Register: DRKS00024015), published in JAMA Oncology, weekly electronic patient-reported outcome (ePRO) monitoring with alert-based clinical response reduced fatigue and improved physical functioning compared with usual care in patients with metastatic breast cancer.1 At 6 months, adjusted mean fatigue was 54.5 (95% CI, 53.7-55.4) in the intervention …
-
-
The Mobile Clinic for Breast Cancer Survivors
-
Transparency Needed in Breast Cancer Care
-
Chemotherapy for the Breast Cancer Patient and the Insurance Companies
-
Breast Cancer Patients Being Compassionate to Others
-
Why Not to Recommend Products and Services as a Breast Cancer Patient
